Project Grant HT94252510111
Award Date
3/1/25
Completion Date
2/28/26
Dollars Obligated
$201K
Federal Agency
Defense Health Agency
Awardee
Yale Univ (FL6GV84CKN57)
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Hamden, CT 06511, USA
Similar Awards
This $859,773 federal Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program supports research at Yale University on biomarkers and targets for leptomeningeal disease progression from non-small cell lung cancer (NSCLC) brain metastasis. The research aims to transform healthcare for military service members and the public by advancing innovative, impactful medical solutions. The award period runs from May 1,...
The Yale University was awarded a $1,244,745 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from July 2021 to June 2025 to overcome resistance to EGFR inhibitors in advanced head and neck cancers. The Military Medical Research and Development program supports biomedical research to transform military and public health care through innovative solutions. This award will further...
The Yale University was awarded a $753,749 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund research from March 2022 through March 2025 to target replication stress in triple-negative breast cancer. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of transforming military and public health care...
The Yale University will receive a $4.9 million project grant award from the Department of the Army Medical Command to conduct research titled "Unraveling Molecular Mechanisms Underlying Chronic Obstructive Pulmonary Disease Heterogeneity Using Combinatorial Barcoding and Single-Nuclear RNA Sequencing." The research will be performed from July 1, 2022 to June 30, 2026. The project aims to investigate the molecular underpinnings of heterogeneity in Chronic Obstructive Pulmonary...
This $249,612 federal Project Grant award was issued by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The award supports research led by Yale University to unravel the causal impact of multiple sclerosis (MS)-associated genetic variants on T cell immune tolerance. The project will be conducted over a 2-year period from September 1, 2025 to August 31, 2027, with the goal of advancing the scientific understanding of MS pathogenesis and...
This $167,071 Project Grant award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program supports research at Yale University on the role of the Downstream of Gene (DOG) transcript in non-small cell lung cancer. The project aims to investigate the impact of cigarette smoke on the DOG transcript and its relationship to lung cancer progression. This research is part of the Defense Health Agency's broader efforts to advance scientific...
Yale University was awarded an $837,500 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development federal grant program (CFDA 12.420). The three-year award will support research into the functional role of RAS/MAPK regulation of N6-methyladenosine (m6A) in melanoma initiation and progression. The Military Medical Research and Development program aims to transform military and public health through innovative biomedical research solutions....
Yale University was awarded a $335,000 project grant from the Defense Health Agency through the Military Medical Research and Development program. The grant will support Yale University's "IMAGING METRIX REMODELING IN PULMONARY FIBROSIS" project from April 1, 2021 to September 30, 2023. The Military Medical Research and Development program aims to transform health care for service members and the public through innovative biomedical research. Under this award, Yale University will...
The Department of the Army Medical Command awarded Yale University $836,788 under the Military Medical Research and Development federal grant program (CFDA 12.420) for the project titled "INFLAMMATION AND CRC: NECROPTOSIS AND FIBROBLASTS TIP THE BALANCE" from August 15, 2022 to August 14, 2025. This Project Grant aims to investigate medical solutions for the battlefield by transforming health care through innovative and impactful research into inflammation and colorectal cancer....
The federal Project Grant award of $1,214,375.00 from the Defense Health Agency, under the Military Medical Research and Development program (CFDA 12.420), is funding a research project led by Yale University. The project is investigating the use of decoy-resistant IL-18 and immune checkpoint inhibitors in preclinical murine and ex vivo patient-derived models of renal cell carcinoma. The award began on September 15, 2024 and is set to conclude on September 14, 2028. The Military Medical Research...